HEADER LIPID BINDING PROTEIN 21-DEC-17 6FD0 TITLE HUMAN KIBRA C2 DOMAIN MUTANT M734I S735A COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN KIBRA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: C2 DOMAIN; COMPND 5 SYNONYM: HBEAG-BINDING PROTEIN 3,KIDNEY AND BRAIN PROTEIN,KIBRA,WW COMPND 6 DOMAIN-CONTAINING PROTEIN 1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: WWC1, KIAA0869; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PQE30 KEYWDS C2 DOMAIN, KIBRA, PHOSPHOINOSITIDE-BINDING, MEMBRANE INTERACTION, KEYWDS 2 LIPID BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR S.J.CRENNELL,M.G.POSNER,S.BAGBY REVDAT 3 17-JAN-24 6FD0 1 REMARK REVDAT 2 27-JUN-18 6FD0 1 JRNL REVDAT 1 16-MAY-18 6FD0 0 JRNL AUTH M.G.POSNER,A.UPADHYAY,R.ISHIMA,A.C.KALLI,G.HARRIS, JRNL AUTH 2 J.KREMERSKOTHEN,M.S.P.SANSOM,S.J.CRENNELL,S.BAGBY JRNL TITL DISTINCTIVE PHOSPHOINOSITIDE- AND CA2+-BINDING PROPERTIES OF JRNL TITL 2 NORMAL AND COGNITIVE PERFORMANCE-LINKED VARIANT FORMS OF JRNL TITL 3 KIBRA C2 DOMAIN. JRNL REF J. BIOL. CHEM. V. 293 9335 2018 JRNL REFN ESSN 1083-351X JRNL PMID 29724824 JRNL DOI 10.1074/JBC.RA118.002279 REMARK 2 REMARK 2 RESOLUTION. 2.64 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.12_2829 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.64 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.56 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.963 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 7788 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.211 REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.294 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.520 REMARK 3 FREE R VALUE TEST SET COUNT : 352 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 26.5577 - 3.8082 0.98 2487 106 0.1775 0.2462 REMARK 3 2 3.8082 - 3.0240 0.99 2522 131 0.2212 0.3244 REMARK 3 3 3.0240 - 2.6422 0.96 2427 115 0.3072 0.4076 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.458 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 36.675 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 57.81 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 74.81 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 2105 REMARK 3 ANGLE : 0.737 2854 REMARK 3 CHIRALITY : 0.047 337 REMARK 3 PLANARITY : 0.003 361 REMARK 3 DIHEDRAL : 12.828 1299 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6FD0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 21-DEC-17. REMARK 100 THE DEPOSITION ID IS D_1200008035. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-FEB-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944+ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 7811 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.620 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.62 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.67 REMARK 200 COMPLETENESS FOR SHELL (%) : 86.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.56500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: BALBES REMARK 200 STARTING MODEL: 6FB4 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.26 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.15M AMMONIUM SULFATE, 0.1M MES PH REMARK 280 6.0, 15% W/V PEG4000, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1860 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13380 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 646 REMARK 465 ARG A 647 REMARK 465 GLY A 648 REMARK 465 SER A 649 REMARK 465 HIS A 650 REMARK 465 HIS A 651 REMARK 465 HIS A 652 REMARK 465 HIS A 653 REMARK 465 HIS A 654 REMARK 465 HIS A 655 REMARK 465 GLY A 656 REMARK 465 MET B 646 REMARK 465 ARG B 647 REMARK 465 GLY B 648 REMARK 465 SER B 649 REMARK 465 HIS B 650 REMARK 465 HIS B 651 REMARK 465 HIS B 652 REMARK 465 HIS B 653 REMARK 465 HIS B 654 REMARK 465 HIS B 655 REMARK 465 GLY B 656 REMARK 465 SER B 657 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 680 -61.51 -92.98 REMARK 500 SER A 706 130.90 59.65 REMARK 500 GLU A 707 45.24 -95.52 REMARK 500 SER A 708 -69.41 -137.97 REMARK 500 ASN A 727 71.18 -113.81 REMARK 500 HIS A 755 50.14 29.19 REMARK 500 LYS B 671 -70.55 -51.33 REMARK 500 SER B 754 -7.56 -59.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PEG A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 802 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6FB4 RELATED DB: PDB REMARK 900 6FB4 CONTAINS ANOTHER MUTANT OF THE SAME PROTEIN DBREF 6FD0 A 658 785 UNP Q8IX03 KIBRA_HUMAN 658 785 DBREF 6FD0 B 658 785 UNP Q8IX03 KIBRA_HUMAN 658 785 SEQADV 6FD0 MET A 646 UNP Q8IX03 INITIATING METHIONINE SEQADV 6FD0 ARG A 647 UNP Q8IX03 EXPRESSION TAG SEQADV 6FD0 GLY A 648 UNP Q8IX03 EXPRESSION TAG SEQADV 6FD0 SER A 649 UNP Q8IX03 EXPRESSION TAG SEQADV 6FD0 HIS A 650 UNP Q8IX03 EXPRESSION TAG SEQADV 6FD0 HIS A 651 UNP Q8IX03 EXPRESSION TAG SEQADV 6FD0 HIS A 652 UNP Q8IX03 EXPRESSION TAG SEQADV 6FD0 HIS A 653 UNP Q8IX03 EXPRESSION TAG SEQADV 6FD0 HIS A 654 UNP Q8IX03 EXPRESSION TAG SEQADV 6FD0 HIS A 655 UNP Q8IX03 EXPRESSION TAG SEQADV 6FD0 GLY A 656 UNP Q8IX03 EXPRESSION TAG SEQADV 6FD0 SER A 657 UNP Q8IX03 EXPRESSION TAG SEQADV 6FD0 ILE A 734 UNP Q8IX03 MET 734 ENGINEERED MUTATION SEQADV 6FD0 ALA A 735 UNP Q8IX03 SER 735 ENGINEERED MUTATION SEQADV 6FD0 MET B 646 UNP Q8IX03 INITIATING METHIONINE SEQADV 6FD0 ARG B 647 UNP Q8IX03 EXPRESSION TAG SEQADV 6FD0 GLY B 648 UNP Q8IX03 EXPRESSION TAG SEQADV 6FD0 SER B 649 UNP Q8IX03 EXPRESSION TAG SEQADV 6FD0 HIS B 650 UNP Q8IX03 EXPRESSION TAG SEQADV 6FD0 HIS B 651 UNP Q8IX03 EXPRESSION TAG SEQADV 6FD0 HIS B 652 UNP Q8IX03 EXPRESSION TAG SEQADV 6FD0 HIS B 653 UNP Q8IX03 EXPRESSION TAG SEQADV 6FD0 HIS B 654 UNP Q8IX03 EXPRESSION TAG SEQADV 6FD0 HIS B 655 UNP Q8IX03 EXPRESSION TAG SEQADV 6FD0 GLY B 656 UNP Q8IX03 EXPRESSION TAG SEQADV 6FD0 SER B 657 UNP Q8IX03 EXPRESSION TAG SEQADV 6FD0 ILE B 734 UNP Q8IX03 MET 734 ENGINEERED MUTATION SEQADV 6FD0 ALA B 735 UNP Q8IX03 SER 735 ENGINEERED MUTATION SEQRES 1 A 140 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER GLY SEQRES 2 A 140 ALA THR ARG ILE GLN ILE ALA LEU LYS TYR ASP GLU LYS SEQRES 3 A 140 ASN LYS GLN PHE ALA ILE LEU ILE ILE GLN LEU SER ASN SEQRES 4 A 140 LEU SER ALA LEU LEU GLN GLN GLN ASP GLN LYS VAL ASN SEQRES 5 A 140 ILE ARG VAL ALA VAL LEU PRO CYS SER GLU SER THR THR SEQRES 6 A 140 CYS LEU PHE ARG THR ARG PRO LEU ASP ALA SER ASP THR SEQRES 7 A 140 LEU VAL PHE ASN GLU VAL PHE TRP VAL SER ILE ALA TYR SEQRES 8 A 140 PRO ALA LEU HIS GLN LYS THR LEU ARG VAL ASP VAL CYS SEQRES 9 A 140 THR THR ASP ARG SER HIS LEU GLU GLU CYS LEU GLY GLY SEQRES 10 A 140 ALA GLN ILE SER LEU ALA GLU VAL CYS ARG SER GLY GLU SEQRES 11 A 140 ARG SER THR ARG TRP TYR ASN LEU LEU SER SEQRES 1 B 140 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER GLY SEQRES 2 B 140 ALA THR ARG ILE GLN ILE ALA LEU LYS TYR ASP GLU LYS SEQRES 3 B 140 ASN LYS GLN PHE ALA ILE LEU ILE ILE GLN LEU SER ASN SEQRES 4 B 140 LEU SER ALA LEU LEU GLN GLN GLN ASP GLN LYS VAL ASN SEQRES 5 B 140 ILE ARG VAL ALA VAL LEU PRO CYS SER GLU SER THR THR SEQRES 6 B 140 CYS LEU PHE ARG THR ARG PRO LEU ASP ALA SER ASP THR SEQRES 7 B 140 LEU VAL PHE ASN GLU VAL PHE TRP VAL SER ILE ALA TYR SEQRES 8 B 140 PRO ALA LEU HIS GLN LYS THR LEU ARG VAL ASP VAL CYS SEQRES 9 B 140 THR THR ASP ARG SER HIS LEU GLU GLU CYS LEU GLY GLY SEQRES 10 B 140 ALA GLN ILE SER LEU ALA GLU VAL CYS ARG SER GLY GLU SEQRES 11 B 140 ARG SER THR ARG TRP TYR ASN LEU LEU SER HET PEG A 801 17 HET GOL A 802 14 HET GOL B 801 14 HET GOL B 802 14 HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 PEG C4 H10 O3 FORMUL 4 GOL 3(C3 H8 O3) FORMUL 7 HOH *2(H2 O) HELIX 1 AA1 LEU A 685 LEU A 688 5 4 HELIX 2 AA2 ALA A 735 GLN A 741 1 7 HELIX 3 AA3 LEU B 685 LEU B 688 5 4 HELIX 4 AA4 ALA B 735 GLN B 741 1 7 SHEET 1 AA1 4 THR A 723 VAL A 732 0 SHEET 2 AA1 4 GLN A 674 SER A 683 -1 N LEU A 682 O LEU A 724 SHEET 3 AA1 4 THR A 660 ASP A 669 -1 N GLN A 663 O GLN A 681 SHEET 4 AA1 4 SER A 777 LEU A 783 -1 O LEU A 783 N THR A 660 SHEET 1 AA2 3 LEU A 712 ARG A 714 0 SHEET 2 AA2 3 LYS A 695 LEU A 703 -1 N VAL A 700 O PHE A 713 SHEET 3 AA2 3 LEU A 718 ASP A 719 -1 O LEU A 718 N VAL A 696 SHEET 1 AA3 4 LEU A 712 ARG A 714 0 SHEET 2 AA3 4 LYS A 695 LEU A 703 -1 N VAL A 700 O PHE A 713 SHEET 3 AA3 4 THR A 743 ASP A 752 -1 O CYS A 749 N ASN A 697 SHEET 4 AA3 4 LEU A 756 SER A 766 -1 O ILE A 765 N LEU A 744 SHEET 1 AA4 3 THR B 723 LEU B 724 0 SHEET 2 AA4 3 GLN B 674 SER B 683 -1 N LEU B 682 O LEU B 724 SHEET 3 AA4 3 GLU B 728 VAL B 732 -1 O PHE B 730 N ILE B 677 SHEET 1 AA5 4 THR B 723 LEU B 724 0 SHEET 2 AA5 4 GLN B 674 SER B 683 -1 N LEU B 682 O LEU B 724 SHEET 3 AA5 4 THR B 660 ASP B 669 -1 N ARG B 661 O SER B 683 SHEET 4 AA5 4 SER B 777 LEU B 783 -1 O LEU B 783 N THR B 660 SHEET 1 AA6 3 LEU B 712 ARG B 714 0 SHEET 2 AA6 3 LYS B 695 LEU B 703 -1 N VAL B 700 O PHE B 713 SHEET 3 AA6 3 LEU B 718 ASP B 719 -1 O LEU B 718 N VAL B 696 SHEET 1 AA7 4 LEU B 712 ARG B 714 0 SHEET 2 AA7 4 LYS B 695 LEU B 703 -1 N VAL B 700 O PHE B 713 SHEET 3 AA7 4 THR B 743 THR B 751 -1 O THR B 743 N LEU B 703 SHEET 4 AA7 4 GLU B 757 SER B 766 -1 O GLY B 761 N VAL B 748 SSBOND 1 CYS A 705 CYS A 711 1555 1555 2.03 SSBOND 2 CYS A 749 CYS A 759 1555 1555 2.05 SSBOND 3 CYS A 771 CYS B 771 1555 1555 2.04 SSBOND 4 CYS B 705 CYS B 711 1555 1555 2.03 SSBOND 5 CYS B 749 CYS B 759 1555 1555 2.05 CISPEP 1 LEU A 703 PRO A 704 0 4.95 CISPEP 2 LEU B 703 PRO B 704 0 1.74 SITE 1 AC1 3 GLN A 663 VAL B 725 ASN B 727 SITE 1 AC2 3 TRP A 780 HOH A 901 GOL B 801 SITE 1 AC3 6 ARG A 779 GOL A 802 ARG B 661 ARG B 779 SITE 2 AC3 6 TRP B 780 GOL B 802 SITE 1 AC4 2 TRP B 780 GOL B 801 CRYST1 34.240 49.049 49.549 62.71 72.07 83.71 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.029206 -0.003220 -0.008958 0.00000 SCALE2 0.000000 0.020511 -0.010312 0.00000 SCALE3 0.000000 0.000000 0.023742 0.00000